Back to company

Pharma IT ApS: Financial statements 2025

CVR: 37320595

Pharma IT ApS (CVR 37320595) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 137,832,741 and a net result of DKK -1,068,285 compared with DKK 21,437,534 the year before. That is a decrease of 15.6% compared with the year before. Equity amounted to DKK 47,568,805. The solvency ratio was 46%. The company had 110 employees in the financial year.

Gross Profit
137,832,741 kr.
Profit/Loss
-1,068,285 kr.
Equity
47,568,805 kr.
Total Assets
103,410,450 kr.
Employees
110

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-137.8 mio.-1.1 mio.47.6 mio.110
2024-163.3 mio.21.4 mio.51.1 mio.112
2023-149.9 mio.13.3 mio.29.7 mio.124
2022-138.6 mio.14.1 mio.16.4 mio.117
2021-84 mio.5.2 mio.8.3 mio.75

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Pharma IT ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2025

Massimo Cunico joins the board of Pharma IT ApSNov 14, 2025

As of November 14, 2025, Massimo Cunico has joined the board of directors of Pharma IT ApS.

Xavier Duburq leaves the board of Pharma IT ApSNov 14, 2025

As of November 14, 2025, Xavier Duburq has left the board of directors of Pharma IT ApS.

Pharma IT ApS: The 2024 annual report is outJul 2, 2025

Pharma IT ApS has published its annual report for 2024. Gross profit came to DKK 163,256,837, and the net result was DKK 21,437,534.

About Pharma IT ApS

Pharma IT ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2015. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Jakob Juul Rasmussen, Søren Winkel and Peter-Emil Iversen. The company is owned by ProductLife ApS. The company has 31 employees. In 2025, the company reported a gross profit of DKK 137,832,741 and a net result of DKK -1,068,285 compared with DKK 21,437,534 the year before. Equity amounted to DKK 47,568,805.